Annovis Bio, Inc. (ANVS): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

20.55M
Year ended 2025-12-31
+36.0%
3-year compound annual growth
+26.6%
5-year compound annual growth
2020-12-31: 6.31M2021-12-31: 7.63M2022-12-31: 8.16M2023-12-31: 9.02M2024-12-31: 12.24M2025-12-31: 20.55M20.55M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3120.55M+68.0%2026-03-13, From 2025-01-01
2024-12-3112.24M+35.6%2026-03-13, From 2024-01-01
2023-12-319.02M+10.5%2025-03-21, From 2023-01-01
2022-12-318.16M+7.0%2024-03-29, From 2022-01-01
2021-12-317.63M+20.9%2023-03-31, From 2021-01-01
2020-12-316.31Mn/a2022-03-02, From 2020-01-01